𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activated astrocytes: a therapeutic target in Alzheimer’s disease?

✍ Scribed by Fuller, Stacey; Münch, Gerald; Steele, Megan

Book ID
120476922
Publisher
Expert Reviews
Year
2009
Tongue
English
Weight
399 KB
Volume
9
Category
Article
ISSN
1473-7175

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypometabolism as a therapeutic target i
Hypometabolism as a therapeutic target in Alzheimer's disease
✍ Lauren C Costantini; Linda J Barr; Janet L Vogel; Samuel T Henderson 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 331 KB

The pathology of Alzheimer's disease (AD) is characterized by cerebral atrophy in frontal, temporal, and parietal regions, with senile plaques, dystrophic neurites, and neurofibrillar tangles within defined areas of the brain. Another characteristic of AD is regional hypometabolism in the brain. Thi

Cdk5, a therapeutic target for Alzheimer
Cdk5, a therapeutic target for Alzheimer's disease?
✍ Li-Huei Tsai; Ming-Sum Lee; Jonathan Cruz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 124 KB

Alzheimer's disease (AD) represents the leading cause for senile dementia affecting more than 4 million people worldwide. AD patients display a triad of pathological features including brain atrophy caused by neuronal loss, h-amyloid plaque and neurofibrillary tangles. We previously show that Cyclin